Sign Out
Relative overdose may be possible in patients with renal impairment if the dose is not adjusted as described in Dosage & Administration. Limited post-marketing experience indicates that adverse events following over dosage are consistent with the adverse event profile described in Adverse Reactions, are generally mild in severity and resolve on withdrawal or dose reduction. Symptomatic treatments should be considered.
In normal individuals rapid renal elimination will occur.
Haemodialysis will remove meropenem and its metabolite.
